| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | 04 Apr 2023 | by Trust | |
| Apollo Endosurgery, Inc. | Director | Common Stock | 0 | $6.46 | 04 Apr 2023 | Direct | |
| Apollo Endosurgery, Inc. | Director | Stock Option (Right to Buy) | 0 | $8.86 | 04 Apr 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | 26 Sep 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | 26 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RETA | REATA PHARMACEUTICALS INC | 26 Sep 2023 | 12 | $0 | 4 | Director | 26 Sep 2023, 16:30 |
| RETA | REATA PHARMACEUTICALS INC | 28 Jul 2023 | 5 | -$690,141 | 4 | Director | 01 Aug 2023, 16:35 |
| RETA | REATA PHARMACEUTICALS INC | 07 Jun 2023 | 4 | $177,321 | 4 | Director | 09 Jun 2023, 16:20 |
| APEN | Apollo Endosurgery, Inc. | 04 Apr 2023 | 9 | $0 | 4 | Director | 04 Apr 2023, 19:55 |
| APEN | Apollo Endosurgery, Inc. | 14 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 21:18 |
| RETA | REATA PHARMACEUTICALS INC | 08 Jun 2022 | 4 | $154,941 | 4 | Director | 09 Jun 2022, 16:37 |
| RETA | REATA PHARMACEUTICALS INC | 03 Jan 2022 | 2 | $3,209 | 4 | Director | 05 Jan 2022, 15:03 |
| APEN | Apollo Endosurgery, Inc. | 17 Jun 2021 | 2 | $46,701 | 4 | Director | 21 Jun 2021, 12:25 |
| RETA | REATA PHARMACEUTICALS INC | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 11:21 |